Pallarés-Carratalá, V.; Ruiz-GarcÃa, A.; Fragoso, A.S.; Escobar-Cervantes, C.; Cervera-Pérez, M.I.; Alonso-Moreno, F.J.; Arranz-MartÃnez, E.; Barquilla-GarcÃa, A.; Rey-Aldana, D.; Polo-GarcÃa, J.;
et al. Improvement of Cardiometabolic Control with Dapagliflozin in Patients with Type 2 Diabetes in Primary Care: The AGORA-AP Study. Medicina 2025, 61, 2087.
https://doi.org/10.3390/medicina61122087
AMA Style
Pallarés-Carratalá V, Ruiz-GarcÃa A, Fragoso AS, Escobar-Cervantes C, Cervera-Pérez MI, Alonso-Moreno FJ, Arranz-MartÃnez E, Barquilla-GarcÃa A, Rey-Aldana D, Polo-GarcÃa J,
et al. Improvement of Cardiometabolic Control with Dapagliflozin in Patients with Type 2 Diabetes in Primary Care: The AGORA-AP Study. Medicina. 2025; 61(12):2087.
https://doi.org/10.3390/medicina61122087
Chicago/Turabian Style
Pallarés-Carratalá, Vicente, Antonio Ruiz-GarcÃa, Antonio Segura Fragoso, Carlos Escobar-Cervantes, MarÃa Inmaculada Cervera-Pérez, Francisco Javier Alonso-Moreno, Ezequiel Arranz-MartÃnez, Alfonso Barquilla-GarcÃa, Daniel Rey-Aldana, José Polo-GarcÃa,
and et al. 2025. "Improvement of Cardiometabolic Control with Dapagliflozin in Patients with Type 2 Diabetes in Primary Care: The AGORA-AP Study" Medicina 61, no. 12: 2087.
https://doi.org/10.3390/medicina61122087
APA Style
Pallarés-Carratalá, V., Ruiz-GarcÃa, A., Fragoso, A. S., Escobar-Cervantes, C., Cervera-Pérez, M. I., Alonso-Moreno, F. J., Arranz-MartÃnez, E., Barquilla-GarcÃa, A., Rey-Aldana, D., Polo-GarcÃa, J., & Cinza-Sanjurjo, S.
(2025). Improvement of Cardiometabolic Control with Dapagliflozin in Patients with Type 2 Diabetes in Primary Care: The AGORA-AP Study. Medicina, 61(12), 2087.
https://doi.org/10.3390/medicina61122087